PMG
IBB icon

ProVise Management Group’s iShares Biotechnology ETF IBB Stock Holding History

ProVise Management Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6,236
Closed -$908K – 273
2024
Q3 		$908K Buy
6,236
+91
+1% +$13.2K 0.07% 157
2024
Q2 		$843K Sell
6,145
-146
-2% -$19.5K 0.07% 154
2024
Q1 		$863K Sell
6,291
-10
-0.2% -$1.37K 0.07% 154
2023
Q4 		$856K Sell
6,301
-21
-0.3% -$2.56K 0.07% 184
2023
Q3 		$773K Sell
6,322
-1,086
-15% -$138K 0.07% 188
2023
Q2 		$941K Sell
7,408
-4,170
-36% -$542K 0.09% 179
2023
Q1 		$1.5M Sell
11,578
-541
-4% -$70.8K 0.14% 135
2022
Q4 		$1.59M Buy
12,119
+2,296
+23% +$297K 0.16% 129
2022
Q3 		$1.15M Buy
9,823
+3,252
+49% +$404K 0.13% 144
2022
Q2 		$773K Sell
6,571
-225
-3% -$26.7K 0.08% 173
2022
Q1 		$886K Sell
6,796
-417
-6% -$54.3K 0.08% 183
2021
Q4 		$1.1M Buy
7,213
+96
+1% +$14.9K 0.1% 175
2021
Q3 		$1.15M Buy
7,117
+552
+8% +$92.9K 0.11% 157
2021
Q2 		$1.07M Sell
6,565
-366
-5% -$56.4K 0.11% 163
2021
Q1 		$1.04M Buy
6,931
+406
+6% +$64.5K 0.11% 157
2020
Q4 		$988K Buy
6,525
+428
+7% +$61.2K 0.11% 150
2020
Q3 		$826K Buy
6,097
+2,127
+54% +$289K 0.11% 155
2020
Q2 		$543K Buy
3,970
+1,131
+40% +$144K 0.08% 175
2020
Q1 		$306K Buy
+2,839
New +$327K 0.05% 214
2017
Q3 		– Sell
-6,156
Closed -$636K – 329
2017
Q2 		$636K Buy
+6,156
New +$606K 0.1% 185

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

ProVise Management Group's IBB Position: Q4 2024 in Review

ProVise Management Group sold out of iShares Biotechnology ETF (IBB) in Q4 2024, closing a stake of 6,236 shares — an estimated $908K sold.

ProVise Management Group first reported a position in IBB in Q2 2017 and held it in 20 quarters. The position peaked at $1.59M in Q4 2022. 874 funds tracked by Wall St. Rank hold IBB as of Q4 2024.

  • ProVise Management Group reported no remaining iShares Biotechnology ETF position as of Q4 2024 after selling out during the quarter.
  • ProVise Management Group sold 6,236 iShares Biotechnology ETF shares in Q4 2024, an estimated $908K.
  • ProVise Management Group first reported a position in iShares Biotechnology ETF in Q2 2017 and held it in 20 quarters.
  • ProVise Management Group's iShares Biotechnology ETF position peaked at $1.59M in Q4 2022.
  • 874 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2024.

Based on ProVise Management Group's 13F filing for Q4 2024, filed 11 Feb 2025.